tiprankstipranks
Trending News
More News >
Novabay Pharmaceuticals (NBY)
:NBY
US Market

NovaBay Pharma (NBY) Financial Statements

Compare
649 Followers

NovaBay Pharma Financial Overview

NovaBay Pharma's market cap is currently $3.37M. The company's EPS TTM is $-7.163; its P/E ratio is ―; NovaBay Pharma is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-0.24. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 9.75M$ 14.73M$ 14.40M$ 8.42M$ 9.93M
Gross Profit$ 6.48M$ 7.89M$ 7.78M$ 5.64M$ 5.96M
Operating Income$ -5.84M$ -5.00M$ -7.68M$ -8.86M$ -6.43M
EBITDA$ -5.92M$ -4.80M$ -7.20M$ -8.74M$ -6.38M
Net Income$ -8.61M$ -9.64M$ -16.27M$ -6.56M$ -11.04M
Balance Sheet
Cash & Short-Term Investments$ 430.00K$ 3.13M$ 5.36M$ 7.50M$ 11.95M
Total Assets$ 3.42M$ 9.03M$ 16.40M$ 23.98M$ 15.24M
Total Debt$ 1.17M$ 2.74M$ 2.04M$ 551.00K$ 503.00K
Net Debt$ 742.00K$ -390.00K$ -3.32M$ -6.95M$ -11.45M
Total Liabilities$ 3.55M$ 5.72M$ 5.84M$ 13.81M$ 2.92M
Stockholders' Equity$ -129.00K$ 3.31M$ 10.55M$ 10.17M$ 12.32M
Cash Flow
Free Cash Flow$ -5.19M$ -4.15M$ -6.77M$ -9.24M$ -4.75M
Operating Cash Flow$ -5.18M$ -4.13M$ -6.65M$ -9.19M$ -4.72M
Investing Cash Flow$ 1.06M$ -19.00K$ -112.00K$ -12.04M$ -26.00K
Financing Cash Flow$ 1.50M$ 1.91M$ 4.63M$ 16.79M$ 9.76M
Currency in USD

NovaBay Pharma Earnings and Revenue History

NovaBay Pharma Debt to Assets

NovaBay Pharma Cash Flow

NovaBay Pharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis